Protagonist Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.About PTGX
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.
PTGX Key Statistics
Stock Snapshot
As of today, Protagonist Therapeutics(PTGX) shares are valued at $86.00. The company's market cap stands at 5.35B, with a P/E ratio of 142.09.
During the trading session on 2025-12-02, Protagonist Therapeutics(PTGX) shares reached a daily high of $89.85 and a low of $85.00. At a current price of $86.00, the stock is +1.2% higher than the low and still -4.3% under the high.
Trading volume for Protagonist Therapeutics(PTGX) stock has reached 999.79K, versus its average volume of 858.56K.
The stock's 52-week range extends from a low of $33.70 to a high of $93.25.
The stock's 52-week range extends from a low of $33.70 to a high of $93.25.
PTGX News
Image source: The Motley Fool. Wednesday, March 10, 2021 at 10:12 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Dinesh Patel Chief Medical Officer — Samu...
In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $89.77, changing hands...
